Updated:
National Human Genome Research Institute
The National Human Genome Research Institute was established in 1989 as the National Center for Human Genome Research. It was formed to carry out the NIH's...
National Human Genome Research Institute
The National Human Genome Research Institute was established in 1989 as the National Center for Human Genome Research. It was formed to carry out the NIH's role in the International Human Genome Project, which began in 1990 with the US Department of Energy. The project aimed to map the human genome. In 1993, the Division of Intramural Research was established to apply genome technologies to disease study. The Center for Inherited Disease Research was established in 1996 to study genetic components of complex disorders.
General information
Firm type
Government Research Institute
Year founded
1989
Location
Region
North America
Country
United States
City
Bethesda
Corporate office
Bethesda, MD, United States
Principals
Eric Green
Director
Sector focus
Frequently asked questions
Who runs investment decisions at NHGRI?
Investment decisions at NHGRI are made through the NIH peer-review system. The institute's director, Eric Green, sets strategic priorities, but grant funding is allocated by external scientific reviewers. Intramural research decisions flow through institute leadership, guided by the NIH scientific mission.
How does NHGRI source proprietary deal flow?
NHGRI does not engage in proprietary deal flow. It funds research through competitive grants and operates an intramural program. Its 'deal flow' is based on investigator-initiated proposals and institute-identified scientific priorities, not market opportunities.
Is NHGRI structured as a single family office or does it operate more like a venture firm?
NHGRI is a federal government research institute under the National Institutes of Health. It operates as a grant-making and research organization, with no resemblance to a family office or venture firm.
Does NHGRI participate in fund commitments or only direct deals?
NHGRI does not participate in fund commitments or direct deals. It provides grants and contracts to academic and research institutions for genomic science. It holds no private investment portfolio.
What investment stages does NHGRI typically target?
NHGRI does not target investment stages. Its funding spans basic research through clinical translation, but it does not invest in equity or debt instruments.
How is NHGRI related to other NIH institutes?
NHGRI is one of 27 institutes and centers at the National Institutes of Health. It collaborates with other institutes on cross-cutting genomic initiatives but operates with its own budget and strategic plan.
Where does the underlying wealth come from?
NHGRI's funding comes from the US federal budget, appropriated by Congress through the NIH. There is no private wealth origin.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: